Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
NCT01397916
·
clinicaltrials.gov ↗
COMPLETED
Status
73
Enrollment
OTHER
Sponsor class
Conditions
CLL
Sponsor
Tampere University Hospital